Solventum Corp (SOLV) income statement
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3091% above fair value
$85.80−0.68 (-0.79%)
Close on Nov 19, 2026Market cap $14.61BP/E 96.4Yield –
Solventum Corp financial ratios
See a number that looks wrong?